Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study.
Khan S, Silsarma A, Mahajan R, Khan S, Davuluri P, Sutar N, Iyer A, Mankar S, Oswal V, Puri V, Shah D, Chavan V, Spencer H, Isaakidis P. Khan S, et al. Among authors: oswal v. J Clin Tuberc Other Mycobact Dis. 2024 Oct 12;37:100481. doi: 10.1016/j.jctube.2024.100481. eCollection 2024 Dec. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 39497757 Free PMC article.
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India.
Agibothu Kupparam HK, Shah I, Chandrasekaran P, Mane S, Sharma S, Thangavelu BR, Vilvamani S, Annavi V, Mahalingam SM, Thiruvengadam K, Navaneethapandian PG, Gandhi S, Poojari V, Nalwalla Z, Oswal V, Giridharan P, Babu SB, Rathinam S, Frederick A, Mankar S, Jeyakumar SM. Agibothu Kupparam HK, et al. Among authors: oswal v. J Antimicrob Chemother. 2024 Nov 4;79(11):2939-2947. doi: 10.1093/jac/dkae311. J Antimicrob Chemother. 2024. PMID: 39308327
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Among authors: oswal vs. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, Oswal V, Iyer A, Morales M, Joshi A, Ferlazzo G, Isaakidis P, Ndlovu Z, England K. Mansoor H, et al. Among authors: oswal v. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):41-48. doi: 10.5588/ijtld.22.0138. Int J Tuberc Lung Dis. 2023. PMID: 36853141 Free PMC article.
Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from adapted N95 mask sampling for emerging variants and interventions.
Sriraman K, Shaikh A, Vaswani S, Mestry T, Patel G, Sakthivel S, Oswal V, Kadam P, Nilgiriwala K, Shah D, Gomare M, Mistry N. Sriraman K, et al. Among authors: oswal v. J Med Virol. 2023 Jan;95(1):e28188. doi: 10.1002/jmv.28188. Epub 2022 Oct 12. J Med Virol. 2023. PMID: 36176180 Free PMC article.
Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
Nilgiriwala K, Kadam P, Patel G, Shaikh A, Mestry T, Vaswani S, Sakthivel S, Poojary A, Gandhi B, Rohra S, Udwadia Z, Oswal V, Shah D, Gomare M, Sriraman K, Mistry N. Nilgiriwala K, et al. Among authors: oswal v. J Med Virol. 2022 Sep;94(9):4206-4215. doi: 10.1002/jmv.27861. Epub 2022 May 25. J Med Virol. 2022. PMID: 35578378 Free PMC article.
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
Dhakulkar S, Das M, Sutar N, Oswal V, Shah D, Ravi S, Vengurlekar D, Chavan V, Rebello L, Meneguim AC, Iyer A, Mansoor H, Kalon S, Acharya S, Ferlazzo G, Isaakidis P, Thakur HP. Dhakulkar S, et al. Among authors: oswal v. PLoS One. 2021 Feb 18;16(2):e0246639. doi: 10.1371/journal.pone.0246639. eCollection 2021. PLoS One. 2021. PMID: 33600431 Free PMC article.
26 results